CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
6 research outputs found
Efficacy and Safety of Ertugliflozin in Patients with Overweight and Obesity with Type 2 Diabetes Mellitus
Author
European Medicines Agency
Ribola FA
US Food and Drug Administration
World Health Organization
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses
Author
Angelos Liontos
Bell RM
+10 more
Byrne NJ
Chang YK
Ioanna Papakitsou
Kimura T
Moses S. Elisaf
Ribola FA
Theodosios D. Filippatos
Tsimihodimos V
Wiviott SD
Zhao Y
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
The effect of SGLT2 inhibitors on cardiovascular events and renal function
Author
American Diabetes Association
Asterios Karagiannis
+16 more
Athyros VG
Food and Drug Administration
Hach T
Haneda M
Hardy E
Ikeda S
Imprialos KP
Inagaki N
Katsiki N
Konstantinos P. Imprialos
Konstantinos Stavropoulos
Michael Doumas
Ribola FA
Saran R
The diabetes control and complication trial research group
Vasilios G. Athyros
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?
Author
A Merovci
AG Bertoni
+33 more
AM Jackson
CG Santos-Gallego
CP Cannon
CS Hummel
DM Williams
E Bertero
E Ferrannini
E Selvin
F Zannad
FA Ribola
GA Nichols
GD Lopaschuk
H Rahmoune
HJL Heerspink
IS Thrainsdottir
IS Thrainsdottir
J Bolinder
J Jensen
JJV McMurray
K Damman
K Damman
ME Nassif
N Sattar
PB Ryan
SD Solomon
SD Wiviott
SV Arnold
T van de Weijer
V Vallon
VW Dennis
WB Kannel
WS Aronow
Y Zhao
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
Author
Abdul-Ghani MA
Baron-Franco B
+54 more
Beck-da-Silva L
Boussageon R
Boussageon R
Braunschweig F
Cefalu WT
Clark AL
Cope LC
Cosentino F
Courtenay M.
Damman K
Dauriz M
Fitchett D
Fonarow GC.
Heerspink HJL
Hemmingsen B
Hormann SM
Huang H
Kimura G.
Kooy A
Kristensen SL
Kristensen SL
Lago RM
Lamanna C
Marso SP
Maruthur NM
McMurray JJV
Mentz RJ
Mogensen UM
Mordi NA
Neal B
Pittman JR
Ponikowski P
Rahelic´ D
Ribola FA
Salem CB
Scirica BM
Seferovic´ PM
Shimbo D
Suskin N
Swedberg K
Taylor CJ
Thompson DR
Turnbull FM
Vaduganathan M
Van Baar MJB
Van Bommel EJM
Vardeny O
Verma S
Wang Y
Wise J.
Wiviott SD
Yudkin JS
Zelniker TA
Zhang XL
Publication venue
'Mark Allen Group'
Publication date
Field of study
No full text
Crossref
The role of the heart failure nurse and use of sodium glucose cotransporter-2 inhibitors
Author
Abdul-Ghani MA
Baron-Franco B
+57 more
Beck-da-Silva L
Boussageon R
Boussageon R
Braunschweig F
Cefalu WT
Clark AL
Cope LC
Courtenay M
Damman K
Dauriz M
Fitchett D
Fonarow GC
Heerspink HJL
Hemmingsen B
Hormann SM
Huang H
Kimura G
Kooy A
Kristensen SL
Kristensen SL
Lago RM
Lamanna C
Marso SP
Maruthur NM
McMurray JJV
Mentz RJ
Mogensen UM
Mordi NA
National Clinical Guideline Centre
National Insitute of Clinical and Health Excellence
National Insitute of Clinical and Health Excellence
Neal B
Pittman JR
Ponikowski P
Rahelić D
Ribola FA
Salem CB
Scirica BM
Seferović PM
Shimbo D
Stewart S
Suskin N
Swedberg K
Taylor CJ
Thompson DR
Turnbull FM
Vaduganathan M
Van Baar MJB
Van Bommel EJM
Vardeny O
Verma S
Wang Y
Wise J
Wiviott SD
Yudkin JS
Zelniker TA
Zhang XL
Publication venue
'Mark Allen Group'
Publication date
Field of study
No full text
Crossref
No full text
No full textNo full text